IBS Diagnosis and Symptoms

Core IBS Symptoms

The American Gastroenterological Association defines IBS as a painful condition with abdominal pain associated with defecation and changes in stool frequency or form 1, 2
Patients with painless bowel dysfunction are classified as having "functional constipation" or "functional diarrhea" rather than IBS, according to the Gut journal 1

Diarrhea is a primary symptom in IBS-D, which accounts for approximately one-third of all IBS cases, as defined by the Rome III classification 1, 2
IBS-M (mixed type) also includes diarrhea alternating with constipation, representing one-third to one-half of IBS patients 1, 3
Post-infectious IBS most commonly presents as IBS-M or IBS-D, according to the Gastroenterology journal 4, 5

Nausea and vomiting are common in IBS patients but reflect overlap with functional dyspepsia rather than being core IBS symptoms, as stated by the Gut journal 1, 3
The guidelines explicitly state that 42% to 87% of IBS patients also have functional dyspepsia, which includes epigastric pain, nausea, vomiting, weight loss, and early satiety 1, 6
Persistent vomiting is an alarm feature requiring immediate medical attention, as it may indicate bowel obstruction or other serious pathology rather than IBS, according to the Praxis Medical Insights 2

Fever combined with vomiting or diarrhea suggests acute gastroenteritis rather than IBS, as indicated by the Gastroenterology journal 4, 5, 2
Nighttime symptoms that wake patients from sleep indicate another diagnosis should be considered, according to the Praxis Medical Insights 2
Rectal bleeding, documented weight loss, or short symptom duration are alarm features requiring investigation, as stated by the Gut journal 1, 3
Age over 50 years at symptom onset warrants further evaluation, according to the Gut journal and Praxis Medical Insights 1, 2

Determine if abdominal pain is present and associated with defecation—this is essential for IBS diagnosis, as stated by the Gut journal and Praxis Medical Insights 1, 2
Assess stool pattern consistency using the Bristol Stool Form Scale to classify IBS subtype, according to the Gastroenterology journal 4, 5
Screen for alarm features that would necessitate investigation beyond symptom-based diagnosis, as indicated by the Gut journal and Praxis Medical Insights 1, 2
Evaluate for functional dyspepsia overlap if nausea and vomiting are prominent, according to the Gut journal and Praxis Medical Insights 1, 6
Consider post-infectious IBS if symptoms began after documented gastroenteritis with fever, vomiting, or diarrhea, as stated by the Gastroenterology journal 4, 5

IBS and functional dyspepsia frequently coexist, with 42% to 87% of IBS patients also experiencing functional dyspepsia symptoms including epigastric pain, nausea, vomiting, and early satiety 7, 8.
The British Society of Gastroenterology recommends that the overall approach to these overlapping functional disorders should be similar, as patients commonly report symptoms of both conditions with variable prominence over time 7, 8.

Antispasmodics with anticholinergic effects, such as Librax, are recommended for abdominal pain in IBS, with the British Society of Gastroenterology noting that the anticholinergic effect appears most effective 8, 9.
The anticholinergic component (clidinium) of Librax reduces intestinal motility and colicky pain, which are core IBS symptoms 10.
Itopride is an efficacious prokinetic agent for functional dyspepsia, with the 2022 British Society of Gastroenterology guidelines providing a weak recommendation with low-quality evidence for its use 11.

The combination of Librax and itopride does not create a direct pharmacological conflict, as they target different segments of the GI tract 10.
The Gut journal guidelines acknowledge that "drugs with conflicting actions are used (prokinetic for constipation and anticholinergic for colicky pain)" and note this is targeted at the symptom perceived as most important by the patient 10.

Verify the patient has both IBS and functional dyspepsia, and rule out alarm features such as age >50 at onset, rectal bleeding, unintentional weight loss, fever, or nighttime symptoms that wake the patient 11.
The British Society of Gastroenterology guidelines recommend considering non-pharmacological therapies, such as dietary modification and psychological interventions, as symptoms improve 11.